Impact of Total Neoadjuvant Therapy vs. Standard Chemoradiotherapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis of Randomized Trials

por Riesco-Martinez, Maria C., Fernandez-Martos, Carlos, Gravalos-Castro, Cristina, Espinosa-Olarte, Paula, La Salvia, Anna, Robles-Diaz, Luis, Modrego-Sanchez, Andrea, Garcia-Carbonero, Rocio
Publicado 2020

A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer

por Okuno, Keisuke, Kandimalla, Raju, Mendiola, Marta, Balaguer, Francesc, Bujanda, Luis, Fernandez-Martos, Carlos, Aparicio, Jorge, Feliu, Jaime, Tokunaga, Masanori, Kinugasa, Yusuke, Maurel, Joan, Goel, Ajay
Publicado 2023

Limited Liver or Lung Colorectal Cancer Metastases. Systemic Treatment, Surgery, Ablation or SBRT

por Molla, Meritxell, Fernandez-Plana, Julen, Albiol, Santiago, Fondevila, Constantino, Vollmer, Ivan, Cases, Carla, Garcia-Criado, Angeles, Capdevila, Jaume, Conill, Carles, Fundora, Yliam, Fernandez-Martos, Carlos, Pineda, Estela
Publicado 2021

Role of Kras Status in Patients with Metastatic Colorectal Cancer Receiving First-Line Chemotherapy plus Bevacizumab: A TTD Group Cooperative Study

por Díaz-Rubio, Eduardo, Gómez-España, Auxiliadora, Massutí, Bartomeu, Sastre, Javier, Reboredo, Margarita, Manzano, José Luis, Rivera, Fernando, Safont, MªJosé, Montagut, Clara, González, Encarnación, Benavides, Manuel, Marcuello, Eugenio, Cervantes, Andrés, Martínez de Prado, Purificación, Fernández-Martos, Carlos, Arrivi, Antonio, Bando, Inmaculada
Publicado 2012

Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer Patients

por Alonso, Vicente, Escudero, Pilar, Fernández-Martos, Carlos, Salud, Antonia, Méndez, Miguel, Gallego, Javier, Rodriguez, Jose-R., Martín-Richard, Marta, Fernández-Plana, Julen, Manzano, Hermini, Méndez, José-Carlos, Zanui, Monserrat, Falcó, Esther, Gil-Raga, Mireia, Rojo, Federico, Cuatrecasas, Miriam, Feliu, Jaime, García-Albéniz, Xabier, Maurel, Joan
Publicado 2018

Prospective Biomarker Study in Advanced RAS Wild‐Type Colorectal Cancer: POSIBA Trial (GEMCAD 10‐02)

por García‐Albéniz, Xabier, Alonso, Vicente, Escudero, Pilar, Méndez, Miguel, Gallego, Javier, Rodríguez, Jose Ramon, Salud, Antonia, Fernández‐Plana, Julen, Manzano, Hermini, Zanui, Montserrat, Falcó, Ester, Feliu, Jaime, Gil, Mireia, Fernández‐Martos, Carlos, Bohn, Uriel, Alonso, Carmen, Calderero, Verónica, Rojo, Federico, Cuatrecasas, Miriam, Maurel, Joan
Publicado 2019

A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 16...

por Español-Rego, Marta, Fernández-Martos, Carlos, Elez, Elena, Foguet, Carles, Pedrosa, Leire, Rodríguez, Nuria, Ruiz-Casado, Ana, Pineda, Estela, Cid, Joan, Cabezón, Raquel, Oliveres, Helena, Lozano, Miquel, Ginés, Angels, García-Criado, Angeles, Ayuso, Juan Ramon, Pagés, Mario, Cuatrecasas, Miriam, Torres, Ferràn, Thomson, Timothy, Cascante, Marta, Benítez-Ribas, Daniel, Maurel, Joan
Publicado 2022

Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer

por Dalgleish, Angus G, Stebbing, Justin, Adamson, Douglas JA, Arif, Seema Safia, Bidoli, Paolo, Chang, David, Cheeseman, Sue, Diaz-Beveridge, Robert, Fernandez-Martos, Carlos, Glynne-Jones, Rob, Granetto, Cristina, Massuti, Bartomeu, McAdam, Karen, McDermott, Raymond, Martín, Andrés J Muñoz, Papamichael, Demetris, Pazo-Cid, Roberto, Vieitez, Jose M, Zaniboni, Alberto, Carroll, Kevin J, Wagle, Shama, Gaya, Andrew, Mudan, Satvinder S
Publicado 2016

ColoLipidGene: signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patients

por Vargas, Teodoro, Moreno-Rubio, Juan, Herranz, Jesús, Cejas, Paloma, Molina, Susana, González-Vallinas, Margarita, Mendiola, Marta, Burgos, Emilio, Aguayo, Cristina, Custodio, Ana B., Machado, Isidro, Ramos, David, Gironella, Meritxell, Espinosa-Salinas, Isabel, Ramos, Ricardo, Martín-Hernández, Roberto, Risueño, Alberto, De Las Rivas, Javier, Reglero, Guillermo, Yaya, Ricardo, Fernández-Martos, Carlos, Aparicio, Jorge, Maurel, Joan, Feliu, Jaime, de Molina, Ana Ramírez
Publicado 2015

Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer

por Dalgleish, Angus G, Stebbing, Justin, Adamson, Douglas J A, Arif, Seema Safia, Bidoli, Paolo, Chang, David, Cheeseman, Sue, Diaz-Beveridge, Robert, Fernandez-Martos, Carlos, Glynne-Jones, Rob, Granetto, Cristina, Massuti, Bartomeu, McAdam, Karen, McDermott, Raymond, Martín, Andrés J Muñoz, Papamichael, Demetris, Pazo-Cid, Roberto, Vieitez, Jose M, Zaniboni, Alberto, Carroll, Kevin J, Wagle, Shama, Gaya, Andrew, Mudan, Satvinder S
Publicado 2016

Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer

por Codony-Servat, Jordi, Cuatrecasas, Miriam, Asensio, Elena, Montironi, Carla, Martínez-Cardús, Anna, Marín-Aguilera, Mercedes, Horndler, Carlos, Martínez-Balibrea, Eva, Rubini, Michele, Jares, Pedro, Reig, Oscar, Victoria, Iván, Gaba, Lydia, Martín-Richard, Marta, Alonso, Vicente, Escudero, Pilar, Fernández-Martos, Carlos, Feliu, Jaime, Méndez, Jose Carlos, Méndez, Miguel, Gallego, Javier, Salud, Antonieta, Rojo, Federico, Castells, Antoni, Prat, Aleix, Rosell, Rafael, García-Albéniz, Xabier, Camps, Jordi, Maurel, Joan
Publicado 2017